Videos
Aortic Regurgitation in 2022 - Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs
James M. McCabe, Vinod H. Thourani, Nadira Hamid, Ravi Ramana and Mark J. Russo discuss JenaValve’s Trilogy System as a solution for severe AR patients at the “Aortic Regurgitation in 2022 – Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs” symposium.
Latest News
View All
Press
April 1, 2026
JenaValve Announces Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the US
Read More
Press
March 18, 2026
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System
Read More
Press
November 24, 2025
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
Read More